Superseded public profile

In clinical trials↗Metabolic↗

Superseded · version 2: Maridebart cafraglutide↗

Related names recorded in this version: MariTide, AMG 133↗

An antibody-peptide conjugate candidate. This profile cites a completed ClinicalTrials.gov study record.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026

We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1

What this version reported

ClinicalTrials.gov lists an Amgen bioavailability study as completed, updated July 21, 2026.↗

Organizations named in cited records:

Trial records: NCT07717814

Sources for this version

  1. 1
    Bioavailability of AMG 133 in Participants With Overweight or Obesity · record history version 1 · last update posted 2026-07-21 ↗

    ClinicalTrials.gov · Official source · Source checked July 22, 2026